Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01929720 · ClinicalTrials.gov registry record · NA

Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors

A NA study of Depression and Pain, sponsored by Ohio State University Comprehensive Cancer Center.

Completed
Registry status
NA
Development phase
33
Enrollment target
1
Study location

NCT01929720: Completed NA study of Depression and Pain, sponsored by Ohio State University Comprehensive Cancer Center.

NCT01929720 is a NA study of Depression and Pain that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 33 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01929720, a NA study of Depression and Pain, has completed, sponsored by Ohio State University Comprehensive Cancer Center.

COMPLETED
Registry status
NA
Development phase
33 participants
Enrollment target
1
Study location

Study Summary

This randomized clinical trial studies a cognitive-behavioral intervention to treat worry, uncertainty, and insomnia in cancer survivors. Counseling may reduce anxiety and insomnia as well as improve the well-being and quality of life of cancer survivors. This study also explores the neuro-immunologic correlates of anxiety and insomnia.

Primary Outcome

A linear mixed model will be used to evaluate the change from pre to post on the Penn State Worry Questionnaire. The model will include group (treatment vs. control), time (pre vs. post), and group-time interaction effects. If the outcome measure is not normally distributed with equal variance across groups, then the outcomes will be log transformed in order to meet these assumptions for the mixed models.

Conditions Studied

Depression Pain Insomnia Fatigue Anxiety Disorder Sleep Disorders Cognitive Behavioral Therapy Worry Uncertainty Psychological Intervention

Interventions

  • BEHAVIORAL Cognitive-behavioral therapy for worry, uncertainty & insomnia

Study Locations (1)

Ohio

  • Wexner Medical Center at The Ohio State University Department of Psychiatry - Columbus

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2011-08
Est. Completion 2014-09
Phase NA
Ohio State University Comprehensive Cancer Center

341 total trials

What the finished NCT01929720 record still lists

NCT01929720 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (96% lower).

The record links to 10 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Cognitive-behavioral therapy for worry, uncertainty & insomnia is the first listed.

NCT01929720 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT01929720 about?

NCT01929720 is a clinical study titled "Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors". This randomized clinical trial studies a cognitive-behavioral intervention to treat worry, uncertainty, and insomnia in cancer survivors. Counseling may reduce anxiety and insomnia as well as improve the well-being and quality of life of cancer survivors. This study also explores the neuro-immunolog...

What is the current status of trial NCT01929720?

This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2011-08. Estimated completion is 2014-09.

What conditions does trial NCT01929720 study?

This clinical trial studies the following conditions: Depression, Pain, Insomnia, Fatigue, Anxiety Disorder.

What interventions are being tested in trial NCT01929720?

The interventions under investigation include: Cognitive-behavioral therapy for worry, uncertainty & insomnia (BEHAVIORAL).

Who is sponsoring clinical trial NCT01929720?

This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01929720 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01929720's enrollment target sits among peer trials

33 549th of 679 higher than 127 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02861898 · 33 participants · Phase 1

    Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma

  • NCT04871607 · 33 participants · Phase 2

    Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma

  • NCT05071937 · 33 participants · Phase 2

    ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer

  • NCT05168618 · 33 participants · Phase 2

    Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT01929720, the US trial registry maintained by the National Library of Medicine. NCT01929720 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.